Interdisciplinary Program for Biomedical Sciences (IPBS) | Osaka University, Institute for Academic Initiatives, Program for Leading Graduate Schools

A discussion meeting with Eli Lilly Japan K.K. was held on Wednesday, July 8.

 Dr. Shinichi Nishiuma, MD.
 Director and Head, Global Patient Safety Japan, Eli Lilly and Company
 Vice-Chairperson, Japanese Association of Pharmaceutical Medicine (JAPhMed)

 gave a talk on an overview of clinical development and safety management for new medicine. During the meeting, the students deepened their understanding on the topic through active discussions among the participants.